Program overview
Context
Indication: Her2-positive/Low-expression Urinary and Digestive Tract Tumors
Mechanism: Unknown
Modality: Unknown
Sponsor: Sichuan Baili Pharmaceutical Co., .
BL-M07D1 is flagged as low signal because public records show limited public risk signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Indication: Her2-positive/Low-expression Urinary and Digestive Tract Tumors
Mechanism: Unknown
Modality: Unknown
Sponsor: Sichuan Baili Pharmaceutical Co., .
Registry: 0/5
Timeline: 1/5
Recruitment burden: 1/5
Results availability: 0/5
Program risk: 1/5
https://clinicaltrials.gov/study/NCT06031584
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT06031584 | Low Signal (RECRUITING) | long_recruitment_duration_signal | Low Signal | rare_population_signal |